Related references
Note: Only part of the references are listed.Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation
L. Webster et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
First Clinical Experience With TRV130: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
David G. Soergel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Circular muscle contraction in the mice rectum plays a key role in morphine-induced constipation
H. Ono et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
William D. Chey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Specific Localization of β-Arrestin2 in Myenteric Plexus of Mouse Gastrointestinal Tract
Hercules T. Maguma et al.
PLOS ONE (2014)
A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphines
Scott M. DeWire et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Regulation of mu-Opioid Receptors: Desensitization, Phosphorylation, Internalization, and Tolerance
John T. Williams et al.
PHARMACOLOGICAL REVIEWS (2013)
Mechanisms That Underlie μ-Opioid Receptor Agonist-Induced Constipation: Differential Involvement of μ-Opioid Receptor Sites and Responsible Regions
Tomohisa Mori et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Differences in the characteristics of tolerance to μ-opioid receptor agonists in the colon from wild type and β-arrestin2 knockout mice
Hercules T. Maguma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Morphine Decreases Enteric Neuron Excitability via Inhibition of Sodium Channels
Tricia H. Smith et al.
PLOS ONE (2012)
The Role of β-Arrestin2 in the Mechanism of Morphine Tolerance in the Mouse and Guinea Pig Gastrointestinal Tract
Minho Kang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Opioid-Induced Constipation: Challenges and Therapeutic Opportunities
Michael Camilleri
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Identification and characterization of seven new exon 11-associated splice variants of the rat mu opioid receptor gene, OPRM1
Jin Xu et al.
MOLECULAR PAIN (2011)
Functional Selectivity at the μ-Opioid Receptor: Implications for Understanding Opioid Analgesia and Tolerance
Kirsten M. Raehal et al.
PHARMACOLOGICAL REVIEWS (2011)
Molecular Insights Into mu Opioid Pharmacology From the Clinic to the Bench
Gavril W. Pasternak
CLINICAL JOURNAL OF PAIN (2010)
Opioid-induced bowel disorders and narcotic bowel syndrome in patients with chronic non-cancer pain
A. K. Tuteja et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Alvimopan for postoperative ileus
Heather R. Bream-Rouwenhorst et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
C-terminal splice variants of the μ-opioid receptor:: existence, distribution and functional characteristics
Sue Oldfield et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Morphine Tolerance in the Mouse Ileum and Colon
Gracious R. Ross et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Morphine leads to contraction of the ileal circular muscle via inhibition of the nitrergic pathway in mice
Hiroki Iwata et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
How important is protein kinase C in μ-opioid receptor desensitization and morphine tolerance?
Chris P. Bailey et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Morphine side effects in beta-arrestin 2 knockout mice
KM Raehal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm
L Pan et al.
NEUROSCIENCE (2005)
Development of tolerance to the inhibitory effect of loperamide on gastrointestinal transit in mice
K Tan-No et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2003)